Triponel Liquid
NDC Package 54859-508-16
Package Information
Triponel (dextromethorphan hbr, phenylephrine hcl, triprolidine hcl) liquids is Useshelps to control the reflex that causes coughingtemporarily relieves nasal congestion due to common cold, hay fever, or other upper respiratory allergies (allergic, rhinitis)temporarily relieves these symptomes due to hay fever or ther upper respiratory allergiesrunny noseitchy, watery eyessneexingitching of the nose or throat. This formulation utilizes a liquid delivery system. Marketed by Llorens Pharmaceuticals International Division, this product is identified by NDC 54859-508 and is authorized under FDA application M012.
Identification & Billing
- RxCUI: 2268058 - dextromethorphan HBr 15 MG / phenylephrine HCl 5 MG / triprolidine HCl 1.25 MG in 5 mL Oral Solution
- RxCUI: 2268058 - dextromethorphan hydrobromide 3 MG/ML / phenylephrine hydrochloride 1 MG/ML / triprolidine hydrochloride 0.25 MG/ML Oral Solution
- RxCUI: 2268058 - dextromethorphan hydrobromide 15 MG / phenylephrine hydrochloride 5 MG / triprolidine hydrochloride 1.25 MG per 5 ML Oral Solution
Clinical Specifications
- Adrenergic alpha1-Agonists - [MoA] (Mechanism of Action)
- Sigma-1 Agonist - [EPC] (Established Pharmacologic Class)
- Sigma-1 Receptor Agonists - [MoA] (Mechanism of Action)
- Uncompetitive N-methyl-D-aspartate Receptor Antagonist - [EPC] (Established Pharmacologic Class)
- Uncompetitive NMDA Receptor Antagonists - [MoA] (Mechanism of Action)
- alpha-1 Adrenergic Agonist - [EPC] (Established Pharmacologic Class)
Regulatory & Marketing
Hierarchy Structure
- 54859 - Llorens Pharmaceuticals International Division
- 54859-508 - Triponel
- 54859-508-16 - 474 mL in 1 BOTTLE
- 54859-508 - Triponel
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 54859-508-16 identifies a specific commercial package of 474 ml in 1 bottle of Triponel, a human over the counter drug labeled by Llorens Pharmaceuticals International Division. This product is billed per "ML" milliliter and contains an estimated amount of 474 billable units per package. This liquid is formulated for oral use and contains dextromethorphan hydrobromide; phenylephrine hydrochloride; triprolidine hydrochloride as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Llorens Pharmaceuticals International Division on August 01, 2019. The current certification is valid through December 31, 2026.
How is this Llorens Pharmaceuticals International Division product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 54859050816. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. There are 474 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.